Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Preventive Medicine|July 9, 2021
Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) surveyRiyad Kherallah, Mahmoud Al Rifai, Ishan Kamat, et al.
JAMA Cardiology|April 21, 2021
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular DiseaseMichelle T Lee, Dhruv Mahtta, David J Ramsey, et al.
Cardiovascular Drugs and Therapy|January 5, 2021
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7Dhruv Mahtta, Michelle T Lee, David J Ramsey, et al.
The American Journal of Medicine|June 30, 2020
Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL RegistryDhruv Mahtta, Angela Gupta, David J Ramsey, et al.
Cardiovascular Drugs and Therapy|February 1, 2021
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare SystemXiaoming Jia, Michelle T Lee, David J Ramsey, et al.
JACC. Cardiovascular Interventions|December 18, 2017
Trends of Incidence, Clinical Presentation, and In-Hospital Mortality Among Women With Acute Myocardial Infarction With or Without Spontaneous Coronary Artery Dissection: A Population-Based AnalysisAhmed N Mahmoud, Siva Sagar Taduru, Amgad Mentias, et al.
Cardiovascular Drugs and Therapy|August 26, 2020
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVDDhruv Mahtta, Sarah T Ahmed, David J Ramsey, et al.
Journal of Clinical Lipidology|October 20, 2021
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare systemXiaoming Jia, Michelle T Lee, David J Ramsey, et al.
JACC. Heart Failure|May 19, 2023
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans AffairsAliza Hussain, David Ramsey, Michelle Lee, et al.
Diabetes Care|January 11, 2022
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans AffairsDhruv Mahtta, David J Ramsey, Michelle T Lee, et al.
Pageof 7